Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11).
Duong Van Huyen
J P
JP
Department of Pathology, Broussais Hospital, France.
Bloch
F
F
Attar
A
A
Levoir
D
D
Kreft
C
C
Molina
T
T
Bruneval
P
P
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003106:Colon / Q000473:pathology*; D003110:Colonic Neoplasms / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology*; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged
D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin